What is the 13F Pro Quality Score for UFPT?

13F Pro ranks UFP TECHNOLOGIES INC (UFPT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View UFPT's current score at https://13fpro.ai/research/UFPT (free sign-up required for the full ranking).

Which hedge funds own the most UFPT stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of UFPT include BlackRock,, WASATCH ADVISORS, CONGRESS ASSET MANAGEMENT CO /MA. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/UFPT as soon as new 13F filings post.

Where does 13F Pro source UFPT data?

All UFP TECHNOLOGIES INC fundamentals and ownership data come directly from SEC EDGAR. UFP TECHNOLOGIES INC files with the SEC under CIK 914156. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is UFPT in?

UFP TECHNOLOGIES INC (UFPT) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is UFPT research updated on 13F Pro?

UFPT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

UFP TECHNOLOGIES INC(UFPT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 914156 UFPT stock profile & AI dashboard →

13F Pro Quality Score

66.6/100

Rank #513 of 2,879 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

82.2/100

Profitability

66.7/100

Balance Sheet

87.3/100

Earnings Quality

69.9/100

Free Cash Flow

66.2/100

Institutional Flow

39.0/100

Revenue Scale

39.7/100

Dilution Risk

47.5/100

UFPT Stock Analysis & AI Quality Score

AI stock analysis and institutional research for UFP TECHNOLOGIES INC (UFPT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UFPT at 66.6/100 on a 32-signal composite quality model, placing it at rank #513 of 2,879 stocks — the top 25% of the AI-ranked universe. UFPT scores in the top quartile across balance sheet strength (87.3), revenue growth (82.2). Areas of concern include institutional flow (39.0) and revenue scale (39.7), which score below median versus the broader universe. Shareholder dilution risk is elevated at 47.5/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), UFP TECHNOLOGIES INC reports quarterly revenue of $154.2M, net income of $17.5M, an operating margin of 15.2%. Top institutional holders of UFPT by reported 13-F value include BlackRock,, WASATCH ADVISORS, CONGRESS ASSET MANAGEMENT CO /MA, based on the most recent SEC filings. UFPT trades on the Nasdaq exchange and files with the SEC under CIK 914156. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UFPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UFP TECHNOLOGIES INC directly from SEC EDGAR. UFP TECHNOLOGIES INC's 13F Pro composite quality score has ranged between 8 and 88 since 2025, currently 66.6 — a stable long-term trajectory across 40 quarterly and live scoring snapshots.

✦

Fun facts about UFP TECHNOLOGIES INC

Quirks, history, and lore behind UFPT — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. small-cap manufacturer · listed on Nasdaq · headquartered in Massachusetts · serves the healthcare and medical markets.
2
The Numbers
Annual revenue in the low hundreds of millions of dollars — not a giant, but a specialist that punches above its weight in high-value custom components.
3
The History
Traces its roots back to the 1940s in New England, growing over decades from a regional packaging operation into a focused advanced materials converter.
4
The Secret
Its real skill is cutting, forming, and laminating foam, fiber, and film into precise shapes — think sterile packaging and single-use surgical components nobody else wants to bother making.
5
The Lore
The company leaned hard into medical device packaging and wound-care components, making it quietly essential to hospital supply chains across North America.
6
The Giveaway
Its ticker is four letters ending in PT, its home is Newburyport, MA, and it literally has the words "Technologies" and "Fabricating Packaging" baked into its DNA.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$154.2M

Net Income

Q1 2026

$17.5M

Free Cash Flow

Q1 2026

$3.2M

Operating Margin

Q1 2026

15.2%

D/E Ratio

Q1 2026

0.34

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+50.7% YoY

$602.8MFY 2025

FY21 $206.3MFY22 $353.8MFY23 $400.1MFY25 $602.8M

Net Income

+52.1% YoY

$68.3MFY 2025

FY21 $15.9MFY22 $41.8MFY23 $44.9MFY25 $68.3M

Operating Income

+60.1% YoY

$92.3MFY 2025

FY21 $21.2MFY22 $55.4MFY23 $57.7MFY25 $92.3M

EPS (Diluted)

+50.1% YoY

$8.75FY 2025

FY21 $2.09FY22 $5.45FY23 $5.83FY25 $8.75

Total Assets

+62.1% YoY

$655.1MFY 2025

FY21 $334.1MFY22 $378.2MFY23 $404.1MFY25 $655.1M

Total Debt

+311.0% YoY

$148.0MFY 2025

FY21 $79.0MFY22 $59.0MFY23 $36.0MFY25 $148.0M

Op. Cash Flow

+122.3% YoY

$91.9MFY 2025

FY21 $14.3MFY22 $17.7MFY23 $41.3MFY25 $91.9M

Metric	FY 2025	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	$602.8M +50.7%	$400.1M +13.1%	$353.8M +71.5%	$206.3M +15.0%	$179.4M -9.6%	$198.4M
Net Income	$68.3M +52.1%	$44.9M +7.5%	$41.8M +163.1%	$15.9M +18.8%	$13.4M -32.3%	$19.8M
Operating Income	$92.3M +60.1%	$57.7M +4.1%	$55.4M +161.1%	$21.2M +26.8%	$16.7M -32.3%	$24.7M
EPS (Diluted)	$8.75 +50.1%	$5.83 +7.0%	$5.45 +160.8%	$2.09 +18.1%	$1.77 -32.7%	$2.63
Total Assets	$655.1M +62.1%	$404.1M +6.9%	$378.2M +13.2%	$334.1M +64.4%	$203.2M +7.7%	$188.8M
Total Debt	$148.0M +311.0%	$36.0M -39.0%	$59.0M -25.3%	$79.0M	$0.00	—
Operating Cash Flow	$91.9M +122.3%	$41.3M +132.9%	$17.7M +24.1%	$14.3M -42.9%	$25.0M -19.8%	$31.2M

AI Insight: UFPT Financial Trends

UFP Technologies is steadily deleveraging post-acquisition while revenue holds near $150M, but Q1 2026 operating cash flow collapsed to $3M — a sharp one-quarter reversal worth watching.

• Total debt fell from $224M in Q3 2024 to $150M in Q1 2026, a $74M reduction in six quarters, reflecting consistent deleveraging.

• Equity grew steadily from $310M in Q2 2024 to $439M in Q1 2026, signaling retained earnings accumulation and a strengthening balance sheet.

• Revenue stabilized in the $148M–$155M range across Q1 2025 through Q1 2026, suggesting modest but consistent top-line growth post-acquisition integration.

• Net income remained flat at $16M–$18M over the last five quarters, with operating income similarly range-bound between $22M–$24M.

⚠ Operating cash flow dropped sharply to $3M in Q1 2026 from $17M in Q4 2025 — lowest reading in the entire dataset.

⚠ Total debt ticked up slightly to $150M in Q1 2026 from $148M in Q4 2025, potentially pausing the deleveraging trend.

⚠ Operating margin has remained flat near 15%–17% since Q1 2025, with no visible expansion despite higher revenues.

AI Insight: UFPT Ratio Trends

UFPT's return metrics have compressed meaningfully since mid-2024, with ROIC falling from 20.8% in Q2 2024 to 15.9% in Q1 2026.

• ROIC declined sharply from 20.8% in Q2 2024 to 15.9% in Q1 2026, a contraction of nearly 5 percentage points.

• Operating margin has drifted lower, from a peak of 17.1% in Q3 2024 to 15.2% in Q1 2026.

• Leverage has improved steadily: D/E fell from 0.68 in Q3 2024 to 0.34 in Q1 2026, signaling debt paydown.

• ROA has been relatively stable, ranging from 10.0% to 10.8% across the last five quarters.

⚠ ROE has declined from 19.9% in Q3 2024 to 16.0% in Q1 2026 — monitor whether profitability improvements can reverse this.

⚠ Operating margin dipped to 14.4% in Q4 2025 before partial recovery to 15.2% — sustainability of the rebound is unconfirmed.

⚠ Continued D/E reduction toward 0.34 is positive, but declining ROIC limits the benefit of lower leverage on shareholder returns.

Get alerted when UFPT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for UFP TECHNOLOGIES INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of UFPT

BlackRock, Inc.
$212.4M1,097,183 sh
WASATCH ADVISORS LP
$150.5M777,313 sh
CONGRESS ASSET MANAGEMENT CO /MA
$101.3M523,438 sh
VANGUARD CAPITAL MANAGEMENT LLC
$63.3M326,725 sh
Boston Trust Walden Corp
$61.4M317,072 sh
STATE STREET CORP
$58.7M303,313 sh
Neuberger Berman Group LLC
$58.2M300,593 sh
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
$44.0M227,303 sh
GEODE CAPITAL MANAGEMENT, LLC
$36.9M190,620 sh
Allspring Global Investments Holdings, LLC
$36.8M189,863 sh

Fund	Value	Shares
BlackRock, Inc.	$212.4M	1,097,183
WASATCH ADVISORS LP	$150.5M	777,313
CONGRESS ASSET MANAGEMENT CO /MA	$101.3M	523,438
VANGUARD CAPITAL MANAGEMENT LLC	$63.3M	326,725
Boston Trust Walden Corp	$61.4M	317,072
STATE STREET CORP	$58.7M	303,313
Neuberger Berman Group LLC	$58.2M	300,593
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$44.0M	227,303
GEODE CAPITAL MANAGEMENT, LLC	$36.9M	190,620
Allspring Global Investments Holdings, LLC	$36.8M	189,863

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put UFPT on your watchlist

Track score changes the day UFP TECHNOLOGIES INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is UFPT a good stock to buy?

13F Pro's AI-powered analysis of UFP TECHNOLOGIES INC (UFPT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for UFPT are available on the UFPT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own UFPT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling UFPT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of UFP TECHNOLOGIES INC's investment landscape.